[Local immunity following treatment with S-carboxymethylcysteine-lysine in tracheotomy patients]. 1992

M T Carlevato, and S Battaglio, and E Galeazzi, and M Bussi
II Clinica Otorinolaringoiatrica, Università di Torino.

Pathological modification in secretory IgA values as well as in circadian rhythms were found in tracheotomized patients in both nasal and tracheo-bronchial secretions. The protective role of the mucosal immune system in addition to the frequency of severe infectious respiratory diseases in laryngectomized patients justifies the efforts of clinicians to prevent and treat such modifications. Mucoregulatory drugs have a peculiar role in these therapeutical attempts. Forty tracheotomized subjects with neoplastic disease were studied. Twenty received SCMC-Lys as a mucoregulatory drug. IgA 7S, 11S and albumin values in nasal and tracheo-bronchial secretions, were evaluated at surgery, 15 and then 40 days later. In accordance with clinical data, an improvement in local antibody production, damaged by tracheostomy, was found in the treated group. The influence of SCMS-Lys on SIgA production, whose evaluation was made by means of an original, highly selective and sensitive Immuno-IsoElectroFocusing procedure, seems to encourage the use of mucoregulatory drugs in laryngectomized patients.

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D007071 Immunoglobulin A, Secretory The principle immunoglobulin in exocrine secretions such as milk, respiratory and intestinal mucin, saliva and tears. The complete molecule (around 400 kD) is composed of two four-chain units of IMMUNOGLOBULIN A, one SECRETORY COMPONENT and one J chain (IMMUNOGLOBULIN J-CHAINS). Colostral IgA,IgA, Exocrine,IgA, Secretory,SIgA,Secretory IgA,Secretory Immunoglobulin A,Exocrine IgA,IgA, Colostral
D007109 Immunity Nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances. Immune Process,Immune Response,Immune Processes,Immune Responses,Process, Immune,Response, Immune
D007825 Laryngectomy Total or partial excision of the larynx. Laryngectomies
D008297 Male Males
D009297 Nasal Mucosa The mucous lining of the NASAL CAVITY, including lining of the nostril (vestibule) and the OLFACTORY MUCOSA. Nasal mucosa consists of ciliated cells, GOBLET CELLS, brush cells, small granule cells, basal cells (STEM CELLS) and glands containing both mucous and serous cells. Nasal Epithelium,Schneiderian Membrane,Epithelium, Nasal,Membrane, Schneiderian,Mucosa, Nasal
D002233 Carbocysteine A compound formed when iodoacetic acid reacts with sulfhydryl groups in proteins. It has been used as an anti-infective nasal spray with mucolytic and expectorant action. 3-(Carboxymethylthio)alanine,Carbocysteine, L-Isomer,Mucodine,Mucodyne,Mukodin,Rhinathiol,S-(Carboxymethyl)-L-cysteine,S-Carboxymethylcysteine,Thiodril,Carbocysteine, L Isomer,L-Isomer Carbocysteine,S Carboxymethylcysteine
D005100 Expectorants Agents that increase mucous excretion. Mucolytic agents, that is drugs that liquefy mucous secretions, are also included here. Expectorant,Mucolytic,Mucolytic Agent,Mucolytic Agents,Mucolytics,Agent, Mucolytic,Agents, Mucolytic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

M T Carlevato, and S Battaglio, and E Galeazzi, and M Bussi
October 2020, Contact dermatitis,
M T Carlevato, and S Battaglio, and E Galeazzi, and M Bussi
October 1994, Research communications in molecular pathology and pharmacology,
M T Carlevato, and S Battaglio, and E Galeazzi, and M Bussi
May 1996, International journal of pediatric otorhinolaryngology,
M T Carlevato, and S Battaglio, and E Galeazzi, and M Bussi
January 1981, The Indian journal of chest diseases & allied sciences,
M T Carlevato, and S Battaglio, and E Galeazzi, and M Bussi
January 1982, Clinical therapeutics,
M T Carlevato, and S Battaglio, and E Galeazzi, and M Bussi
January 2001, BMC family practice,
M T Carlevato, and S Battaglio, and E Galeazzi, and M Bussi
January 1974, Current medical research and opinion,
M T Carlevato, and S Battaglio, and E Galeazzi, and M Bussi
January 1980, European journal of drug metabolism and pharmacokinetics,
M T Carlevato, and S Battaglio, and E Galeazzi, and M Bussi
September 1994, The European respiratory journal,
M T Carlevato, and S Battaglio, and E Galeazzi, and M Bussi
March 1979, Minerva pediatrica,
Copied contents to your clipboard!